660440-57-3

Usage

Uses

4-(2-Ethoxycarbonylethyl)phenylboronic acid

InChI:InChI=1/C11H15BO4/c1-2-16-11(13)8-5-9-3-6-10(7-4-9)12(14)15/h3-4,6-7,14-15H,2,5,8H2,1H3

Upstream product

• 64-17-5 ethanol 
• 166316-48-9 4-(2-carboxyethyl)benzeneboronic acid 
• 40640-98-0 3-(4-bromo-phenyl)-propionic acid ethyl ester 
• 490035-79-5 ethyl 3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]propanoate 

Downstream Products

• 864653-93-0 3-(4-pyridin-3-yl-phenyl)propionic acid ethyl ester 
• 850568-48-8 [4-(3-hydroxypropyl)phenyl]boronic acid 
• 1374261-18-3 methyl 3-(4-{3-[4-(1-aminocyclobutyl)phenyl]-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-2-yl}phenyl)propanoate 
• 1157581-03-7 3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester 
• 1204423-24-4 C₂₄H₂₆N₂O₄ 
• 1204423-25-5 4-{3-[4-(4-methoxyphenyl)phenyl]propanoyl}amino-1-methylpyrrole-3-carboxylic acid 
• 1204422-11-6 4-{3-[4-(4-Hydroxyphenyl)phenyl]propanoyl}amino-1-methylpyrrole-3-carboxylic acid 
• 1186483-32-8 3-(4-{6-[2-(2,3-Difluoro-phenyl)-imidazo[4,5-d]pyridazin-5-ylmethyl]-pyridazin-3-yl}-phenyl)-propionic acid ethyl ester 
• 166316-48-9 4-(2-carboxyethyl)benzeneboronic acid 

Relevant academic research and scientific papers

NOVEL COMPOUNDS

The present invention relates to novel pyridone derivatives capable of inhibiting a4 integrin medicated cell adhesion, processes for their preparation, compositions comprising them and their use in the treatment of diseases capable of being modulated by t

Syntheses with organoboranes. XIII. Synthesis of ω-(4-bromophenyl)alkanoic acids and their borylation

ω-(4-Bromophenyl)alkanoic acids 2c-e were obtained from 1-bromo-4-alkenylbenzenes 5c-e by hydroboration-thermal isomerization-oxidation. Their esters 11c-e were transformed in good yields into the corresponding boronates 12c-e by the cross-coupling reaction with (10) in an ionic liquid, [bmim][BF4]. The use of pinacolborane for the coupling reaction in the ionic liquid gave debromination products, and low yields of 12c-e. Ethyl 3-(4-bromophenyl)propanoate (7c) was transformed into ethyl 3-(4-[1,3,2]dioxaborolanyl)propanoate (9c) by the cross-coupling with [2,2′]bi[[1,3,2]dioxaborinanyl].